Any improvement that is recognised by the company is good news for me, for me if i have 3 easily read, exciting investment docs and one poorly scanned 4th generation black and white , i know which ones i favour, Biotechs now realise the data has to be easily digestible by the general investment public as well as the technical industry boffins...
so i look forward to the next announcement to see the level of copy to have risen as well as clear concise diagrams...
Any improvement that is recognised by the company is good news...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.025(6.67%) |
Mkt cap ! $25.68M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.0¢ | $387.8K | 1.079M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 394907 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 15948 | 1 |
View Market Depth
| Last trade - 16.10pm 12/12/2024 (20 minute delay) ? |
| DXB (ASX) Chart |